During the past decade, Quest Clinical Research conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 28 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 17 clinical trials were completed. i.e. 141.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Quest Clinical Research" #1 sponsor was "Gilead Sciences" with 12 trials, followed by "Assembly Biosciences" with 6 trials sponsored, "Bristol-Myers Squibb" with 6 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored and "TaiMed Biologics Inc." with 5 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Quest Clinical Research" #1 collaborator was "Amarex Clinical Research" with 3 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Aaron Diamond AIDS Research Center" with 1 trials as a collaborator, "Bill and Melinda Gates Foundation" with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Quest Clinical Research" are "HIV Infections" (16 trials), "Hepatitis C" (9 trials), "Chronic Hepatitis B" (6 trials), "Chronic Hepatitis C" (6 trials) and "HIV" (6 trials). Many other conditions were trialed in "Quest Clinical Research" in a lesser frequency.

Most popular intervention types in "Quest Clinical Research" are "Drug" (64 trials), "Biological" (14 trials), "Genetic" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "RBV" (7 trials), "Sofosbuvir" (6 trials), "Ribavirin" (4 trials) and "ABI-H0731" (3 trials). Other intervention names were less common.

The vast majority of trials in "Quest Clinical Research" are 79 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Quest Clinical Research". undefined are not yet recruiting, 5 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 55 completed trials in Quest Clinical Research, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Quest Clinical Research, 19 "Phase 1" clinical trials were conducted, 41 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".